Mitochondrial Ca 21 homeostasis has a key role in the regulation of aerobic metabolism and cell survival 1 , but the molecular identity of the Ca 21 channel, the mitochondrial calcium uniporter 2 , is still unknown. Here we have identified in silico a protein (named MCU) that shares tissue distribution with MICU1 (also known as CBARA1), a recently characterized uniporter regulator 3 , is present in organisms in which mitochondrial Ca 21 uptake was demonstrated and whose sequence includes two transmembrane domains. Short interfering RNA (siRNA) silencing of MCU in HeLa cells markedly reduced mitochondrial Ca 21 uptake. MCU overexpression doubled the matrix Ca 21 concentration increase evoked by inositol 1,4,5-trisphosphate-generating agonists, thus significantly buffering the cytosolic elevation. The purified MCU protein showed channel activity in planar lipid bilayers, with electrophysiological properties and inhibitor sensitivity of the uniporter. A mutant MCU, in which two negatively charged residues of the putative pore-forming region were replaced, had no channel activity and reduced agonist-dependent matrix Ca 21 concentration transients when overexpressed in HeLa cells. Overall, these data demonstrate that the 40-kDa protein identified is the channel responsible for ruthenium-red-sensitive mitochondrial Ca 21 uptake, thus providing a molecular basis for this process of utmost physiological and pathological relevance.
rapid, uncoupler-sensitive Ca 21 fluxes to mitochondria were measured 20, 21 . This list ( Supplementary Table 1 ) included 13 proteins with either already characterized functions (complex I subunits, assembly regulators, and so on) or poor alignment scores. The remaining protein (NP_001028431) includes a highly conserved domain comprising two transmembrane regions and an intervening loop enriched in acidic residues (Fig. 1a) , indicative of a possible common role in cation permeation. This domain was also detected by hidden Markov model-based analysis of evolutionary conserved proteins (Pfam PF04678 and Panther PTHR1346 domains, with undefined function), further supporting the significance of the hit. We thus considered this protein a putative mitochondrial Ca 21 channel, named it MCU (mitochondrial calcium uniporter) and characterized it in detail. Tissue expression profiling by real-time PCR showed ubiquitous presence in all investigated tissues ( Fig. 1b) , in agreement with a housekeeping role, with expression levels correlating with those of MICU1. To verify the role of MCU in mitochondrial Ca 21 handling, siRNA oligonucleotides were synthesized and tested ( Supplementary Fig. 1 ), Ca 21 measurements were then carried out with aequorin-based mitochondrial and cytosolic Ca 21 probes (mtAEQ and cytAEQ) ( Fig. 2a and Supplementary Fig. 1 ). MCU-silenced and control HeLa cells, perfused with modified Krebs-Ringer buffer supplemented with 1 mM CaCl 2 (KRB), were challenged, where indicated, with 100 mM histamine, an inositol 1,4,5-trisphosphate-generating agonist causing Ca 21 release from the endoplasmic reticulum. In control cells, the [Ca 21 ] mt rise evoked by histamine stimulation was ,63 mM ( Fig. 2a ). In MCU-silenced cells mitochondrial Ca 21 accumulation was markedly reduced (peak value ,30 mM and ,16 mM 48 h and 72 h after silencing, respectively). The marked reduction was specific of mitochondria, as [Ca 21 ] cyt rises were almost unaffected (rather, a small but significant increase was detected, possibly due to reduced mitochondrial buffering) ( Fig. 2b ). Overexpression of MICU1 did not rescue the [Ca 21 ] mt reduction in MCU-silenced cells, and had a marginal effect in control cells ( Supplementary Fig. 2 ). Experiments were then carried out to exclude that the observed effect was secondary to changes in mitochondrial morphology (that is, fragmentation, swelling or redistribution away from the endoplasmic reticulum) or in the driving force for Ca 21 accumulation (that is, a collapse of mitochondrial membrane potential, DY). On the former aspect, mitochondria and endoplasmic reticulum were labelled in living cells by co-expressing red and green fluorescent protein specifically targeted to the mitochondria and endoplasmic reticulum compartments (mtRFP and erGFP; Fig. 2c and Supplementary Fig. 3 ). mtRFP imaging showed the typical threedimensional interconnected network, with no difference in mitochondrial number and volume between control and MCU-silenced cells ( Fig. 2d, e ). Also the endoplasmic reticulum showed a similar distribution in control and MCU-silenced cells, and no difference was detected in the number of mtRFP/erGFP fluorescence overlaps, whereas in cells in which the endoplasmic reticulum/mitochondria tether mitofusin 2 (MFN2) 22 was silenced a marked reduction was observed ( Fig. 2f and Supplementary Fig. 3 ). As to the driving force for Ca 21 uptake, no difference was detected in the loading of the fluorescent dye tetramethyl rhodamine methyl ester (TMRM) ( Fig. 2g ), thus ruling out a DY drop in MCU-silenced cells. In brief, mitochondria simply seem to have an intrinsically reduced ability of accumulating Ca 21 . Direct evidence was obtained by permeabilizing MCU-silenced and control cells in intracellular buffer, containing 100 mM EGTA (Ca 21 -free) and then imposing an EGTA-buffered fixed [Ca 21 ] of 2 mM (2 mM Ca 21 ). Under those conditions, in MCU-silenced cells Ca 21 uptake was initiated at a speed that was threefold lower than controls ( Fig. 2h ).
To demonstrate that MCU promotes Ca 21 uptake, overexpression experiments were carried out. The full-length complementary DNA of the protein, obtained by PCR after reverse transcription from skeletal muscle RNA, was identical to that deposited in the NCBI databank (NM_001033259). The cDNA was cloned in pcDNA3.1 and coexpressed with aequorin probes. MCU-overexpressing cells showed a marked increase in the histamine-evoked [Ca 21 ] mt rise (106%, ,169 mM in MCU-overexpressing vs ,82 mM in control cells, Fig. 3a ). The greater mitochondrial response was not secondary to 
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alterations of the cytosolic response. Rather, a significant reduction in the [Ca 21 ] cyt transient was observed, most probably because of increased Ca 21 clearance by mitochondria ( Fig. 3b ). Enhanced mitochondrial Ca 21 uptake was confirmed also upon capacitative Ca 21 influx ( Supplementary Fig. 4 ) and in permeabilized cells ( Fig. 3c ). As in Fig. 2h , mitochondrial Ca 21 uptake was initiated by switching the medium, after digitonin permeabilization, from intracellular buffer/ EGTA (Ca 21 -free) to intracellular buffer/Ca 21 (3 mM Ca 21 ). MCUoverexpressing cells showed a faster rate of Ca 21 uptake and reached a higher plateau level ( Fig. 3c ). Finally, we verified whether the increased intrinsic ability of mitochondria to accumulate Ca 21 correlated with sensitivity to apoptotic challenges ( Fig. 3d ). Microscopy counts of cell viability after treatment with C2-ceramide or H 2 O 2 showed that MCU-expressing cells were more efficiently killed, thus confirming the notion that mitochondrial Ca 21 loading synergizes with these apoptotic stimuli 12, 23 . We then investigated the subcellular distribution of MCU. For this purpose, tagged versions of MCU were generated (MCU-GFP and MCU-Flag), that had the same effect on [Ca 21 ] mt as MCU (Supplementary Fig. 5 ). GFP fluorescence and immunocytochemistry labelling with anti-Flag antibody completely overlapped with mitochondrial markers ( Supplementary Fig. 6 ). Then, intra-mitochondrial distribution and topology was investigated. HeLa cells were transfected with MCU-GFP (or the matrix probe mtGFP) and harvested. The mitochondrial fraction was obtained by differential centrifugation and either blotted directly, or subjected to osmotic swelling, thus obtaining the mitoplast fraction devoid of the outer membrane. Both MCU and mtGFP were progressively more enriched in the mitochondrial and mitoplast fractions ( Fig. 3e ). Mitochondrial localization was also confirmed by immuno-electron microscopy of HeLa cells expressing MCU-Flag ( Supplementary Fig. 7 ). To show the inner membrane localization and get information on the topology of MCU, we carried out an experiment in digitonin-permeabilized cells, in which GFP fluorescence was visualized before and after treatment with proteinase K or Trypan blue, a fluorescence quencher that crosses the outer, but not the inner mitochondrial membrane 9 (Fig. 3f ). Proteinase K had no effect on MCU-GFP fluorescence (but abrogated fluorescence of the cytosolic, outer mitochondrial membraneanchored N33-D1cpV probe, confirming that MCU is not on the outer mitochondrial membrane), whereas Trypan blue abrogated MCU-GFP (but not mtGFP) fluorescence ( Fig. 3f ), thus demonstrating that MCU is in the inner mitochondrial membrane, with the carboxy terminus most probably located in the intermembrane space ( Fig. 3g ).
Finally, we investigated the channel activity of the purified protein reconstituted in a planar lipid bilayer. For this purpose, a His-tagged MCU was generated and expressed in two different heterologous expression systems, Escherichia coli and wheat-germ cell-free transcription/translation. The purified protein ( Supplementary Fig. 8 ) was inserted into lipid bilayers, and its electrophysiological activity was assessed in a medium containing only Ca 21 as cation. With both preparations, we measured channel activity, with the properties previously reported for the uniporter 17, 24 : conductance of 6-7 pS (in the 
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negative voltage range applied in the cis compartment), fast kinetics, low probability of opening at low voltages (P o ), P o increase with voltage, and inhibition by ruthenium red and the lanthanide gadolinium (Gd 31 ) ( Fig. 4a and b and Supplementary Fig. 9 ). Then, to get evidence of cation permeation across the putative pore-forming domain, we mutated into glutamines two negatively charged residues of the conserved region (D260Q and E263Q) and assessed the electrophysiological properties of the mutant protein (MCU D260Q,E263Q ) produced in vitro. MCU D260Q,E263Q failed to give rise to Ca 21permeable channel activity in bilayer experiments, whereas in the same membrane the subsequent addition of MCU initiated channel activity with the characteristics described above (Fig. 4c ). MCU D260Q,E263Q , when overexpressed in HeLa cells, showed the same membrane topology as MCU ( Supplementary Fig. 10 ) and caused a marked reduction in histamine-induced [Ca 21 ] mt rises, both compared to MCU-overexpressing and control cells (Fig. 4d ). MCU D260Q,E263Q thus acts as a dominant-negative mutant, most probably by either inhibiting MCU channel activity within an oligomer or competing for docking sites or essential regulators.
In conclusion, we have identified a 40-kDa protein which fulfils the requirements for being the long searched for mitochondrial calcium uniporter: it contains two transmembrane domains and shows channel activity in vitro with the previously characterized properties of the uniporter, it is localized in the inner membrane and, finally, it markedly enhances mitochondrial Ca 21 uptake upon overexpression. The availability of molecular information opens the mitochondrial checkpoint in cellular Ca 21 signalling to a deeper understanding. Informative animal models can now be generated and new drugs developed to influence processes regulated by mitochondrial Ca 21 signals, such as aerobic metabolism and cell death.
METHODS SUMMARY
Candidate mouse genes coding for the mitochondrial calcium uniporter were searched starting from the MitoCarta database. Bioinformatic analysis was performed by selecting candidates according to the following parameters: (1) genes expressed in most mammalian tissues, (2) the presence of two or more transmembrane domains, (3) without any homologues in Saccharomyces cerevisiae but (4) conserved in kinetoplastids. The resulting 14 candidates were manually screened to search for highly conserved putative channel-forming domains.
All the experiments were performed in HeLa cells. MCU was silenced using specific siRNAs. The MCU cDNA was retro-transcribed and amplified from mouse skeletal muscle messenger RNA and overexpressed after cloning in several expression plasmids.
[Ca 21 ] cyt and [Ca 21 ] mt were measured in MCU-silenced and MCUoverexpressing cells using appropriate cytosolic and mitochondrial probes 25 .
Morphology of MCU-silenced cells was evaluated using GFP and RFP specifically targeted to the mitochondria and endoplasmic reticulum compartments (erGFP and mtRFP) 6 .
MCU mitochondrial localization was demonstrated by confocal imaging of cells transfected with the MCU-GFP expression vector and loaded with MitoTracker Red and by fractionation and western blotting of cells overexpressing MCU-GFP, as previously described 26 .
Reconstitution in planar lipid bilayer was carried out with the purified protein from both E. coli and in vitro transcription/translation using 100 mM CaCl 2 . Bilayers of approximately 150-200 pF capacity were prepared using purified soybean azolectin.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
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METHODS
Bioinformatic screening. The MitoCarta database was screened for ubiquitously expressed proteins (expressed in at least 12 out of 14 tissues analysed, obtaining 529 candidates) and proteins containing two or more transmembrane domains were selected using the TMHMM algorithm 27 . Out of 1,098 proteins present in MitoCarta, 89 fulfilled these requirements. Sequences of these candidates were retrieved and aligned with the Saccharomyces cerevisiae proteome by a standard Gonnet matrix to exclude homologues. All alignments with a P-value , 0.001 were excluded. Out of 89, 20 remained and were subsequently aligned with kinetoplastids proteomes using the TriTrypDB server. Out of 20, 14 had significant scores. These candidates were manually aligned through different species to look for putative highly conserved channel-forming domains.
RNA extraction and gene expression analyses. For the expression analysis of MCU and MICU1 in mouse tissues, adult male C57BL/6 mice (28-30 g) were used. Skeletal muscles (tibialis anterior), heart, brain, spleen, lung, liver, kidney and visceral fat were excised from three age-matched animals. Total RNA was purified using an SV Total RNA Isolation kit (Promega) following manufacturer instructions. The RNA was quantified and controlled for its quality using a RNA 6000 LabChip kit (Agilent Technologies) in conjunction with an Agilent Bioanalyzer 2001. An equal amount of total RNA from the three animals was pooled together for each organ, complementary DNA was generated with a cDNA synthesis kit (SuperScript VILO, Invitrogen) and analysed by real-time PCR using the SYBR green chemistry (Bio-Rad). The primers were designed and analysed with Primer3. Identity of the amplicons was confirmed by their dissociation profiles and gel analysis. Real-time PCR standard curves were constructed by using serial dilutions of pooled cDNAs of the analysed samples, using at least four dilution points and the efficiency of all primer sets was between 95 and 105%. Real-time PCR primer sequences were as follows: MICU1-fw, 59-GTCGAACTCTCGGACCATGT-39; MICU1-rv, 59-CAAAGTCCC AGGCAGTTTCT-39. These primers amplify a fragment of 199 base pairs. MCU-fw, 59-AAAGGAGCCAAAAAGTCACG-39; MCU-rv, 59-AACGGCGTGAGTTAC AAACA-39. These primers amplify a fragment of 200 bp. For the expression analysis of MCU silencing, total RNA was purified from HeLa cells transfected with scrambled, siRNA-MCU#1 and siRNA-MCU#2 for 48 h following the standard TRIzol protocol. The RNA was quantified, controlled for its quality and retrotranscribed as described earlier. Complementary DNA was analysed by real-time PCR using the SYBR Green chemistry (Bio-Rad). All data were normalized to GAPDH expression. The oligonucleotide primers specific for MCU are the same as above. The oligonucleotide primers specific for GAPDH are the following: GADPH-fw, 59-CACCATCTTCCAGGAGCGAG-39; GADPH-rv, 59-CCTTCTC CATGGTGGTGAAGAC-39. These primers amplify a fragment of 101 bp. Constructs and siRNA. Mouse MCU (NM_001033259) was amplified from mouse skeletal muscle cDNA by PCR using the following primers.
For cloning into pEGFP-N1: fw, 59-GAATTCGCCACCATGGCGGCCGCCG CAGGTAG-39; rv, 59-GGATCCACTTCCTTTTCTCCGATCTGTCG-39. The PCR fragment was cloned into EcoRI and BamHI sites in pEGFP-N1 (Clontech).
For cloning into pcDNA3.1: fw, 59-GGTACCGCCACCATGGCGGCCGCC GCAGGTAG-39; rv, 59-GAATTCTCATTCCTTTTCTCCGATCTGTC-39. The PCR fragment was cloned into KpnI and EcoRI sites in pcDNA3.1 (Invitrogen).
For the cloning of MCU-Flag into pcDNA3.1: fw, 59-GGTACCGCCACCA TGGCGGCCGCCGCAGGTAG-39; rv, 59-GGAATTCTCACTTATCGTCGTC ATCCTTGTAATCTTCCTTTTCTCCGATCTGTC-39. The PCR fragment was cloned into KpnI and EcoRI sites in pcDNA3.1 (Invitrogen).
For the cloning of MCU in pET-28A(1): fw, 59-AGGATCCATGGCGGCCG CCGCAGGTAG-39; rv, 59-ACTCGAGTCATTCCTTTTCTCCGATCT-39. The PCR fragment was cloned into BamHI and XhoI sites in pET-28A(1) (Novagen).
For the cloning of MCU deleted of the mitochondrial targeting sequence (amino acids 1-54) (MCU DMTS ) in pET-28A(1): fw, 59-CATATGGCTTCCTGGC AGAGCGTGGG-39; rv, 59-CTCGAGTCATTCCTTTTCTCCGATCT-39. The PCR fragment was cloned into NdeI and XhoI sites in pET-28A(1) (Novagen).
For the cloning of MCU in pIVEX 1.3 WG: fw, 59-ACATATGGCGGCCGC CGCAGGTAGATC-39; rv, 59-TCTCGAGTTCCTTTTCTCCGATCTGTC-39. The PCR fragment was cloned into NdeI and XhoI sites in pIVEX 1.3 WG (Roche).
The generation of the pcDNA3.1-MCU D260Q,E263Q -Flag and pEGFP-N1-MCU D260Q,E263Q mutant was performed by mutagenesis PCR using the wild type pcDNA3.1-MCU-Flag and pEGFP-N1-MCU vectors as template and the mutagenesis primer: 59-CTGGTGGGAGTACTCGTGGCAAATCATGCAACCCGT CACCTACTTCATCAC-39.
Mouse MICU1 (NM_144822) was amplified from mouse skeletal muscle cDNA by PCR using the following primers:
For the cloning of MICU1-HA in pcDNA3.1: fw, 59-CGGATCCGCCACCAT GTTTCGTCTTAACACCCT-39; rv, 39-GCTCGAGTCACAGGGAAGCGTAGT CAGGCACATCGTAGGGGTATTTGGGCAGAGCAAAGTCCC-59. The PCR fragment was cloned into BamHI and XhoI sites in pcDNA3.1 (Invitrogen).
For the cloning of MICU1 in pEGFP-N1: fw, 59-CCTCGAGATGTTTCGTC TTAACACCCT-39; rv, 59-CGGATCCCGTTTGGGCAGAGCAAAGTCCC-39. The PCR fragment was cloned into XhoI and BamHI sites in pEGFP-N1 (Clontech).
To silence MCU specific siRNA were designed: siRNA-MCU#1: nucleotides 899-917 of the corresponding mRNA (59-GCCAGAGACAGACAAUACUtt-39 and 39-ttCGGUCUCUGUCUGUUAUGA-59. siRNA-MCU#2: nucleotides 360-378 of the corresponding mRNA (59-GGGAAUUGACAGAGUUGCUtt-39and 39-ttCCCUUAACUGUCUCAACGA-59). The non-targeting siRNA (scrambled) is the following: 59-GCCUAAGAACGACAAAUCAtt-39 and 39-ttCGGAUUCU UGCUGUUUAGU-59. Cell culture and transfection. In all the experiments HeLa cells were used. Cells were grown in Dulbecco's modified Eagle's medium (DMEM) (Euroclone), supplemented with 10% fetal bovine serum (FBS) (Euroclone) and transfected with a standard calcium-phosphate procedure. For aequorin measurements, the cells were seeded 24 h before transfection onto 13 mm glass coverslips and allowed to grow to 50% confluence before transfection. For morphologic analyses cells were seeded 24 h before transfection onto 24-mm glass coverslips and allowed to grow to 50% confluence before transfection, unless otherwise specified. Aequorin measurements. HeLa cells grown on 13-mm round glass coverslips at 50% confluence were transfected with the cytosolic (cytAEQ) or the low-affinity mitochondrial (mtAEQmut, referred in the text as mtAEQ) probe (as previously described 25 ) together with the indicated siRNA or plasmid. pcDNA3.1 was used as control unless otherwise indicated. The coverslip with the cells was incubated with 5 mM coelenterazine for 1-2 h in KRB (Krebs-Ringer modified buffer: 125 mM NaCl, 5 mM KCl, 1 mM Na 3 PO 4 , 1 mM MgSO 4 , 5.5 mM glucose, 20 mM HEPES, pH 7.4, 37 uC) supplemented with 1 mM CaCl 2 , and then transferred to the perfusion chamber. All aequorin measurements were carried out in KRB. Agonists and other drugs were added to the same medium, as specified in the text. The experiments were terminated by lysing the cells with 100 mM digitonin in a hypotonic Ca 21 -rich solution (10 mM CaCl 2 in H 2 O), thus discharging the remaining aequorin pool. The light signal was collected and calibrated into [Ca 21 ] values by an algorithm based on the Ca 21 response curve of aequorin at physiological conditions of pH, [Mg 21 ] and ionic strength, as previously described 25 . Representative traces are shown in the figures whereas the full data set is included in Supplementary Table 2 . In the experiments with permeabilized cells, a buffer mimicking the cytosolic ionic composition, (intracellular buffer) was used: 130 mM KCl, 10 mM NaCl, 2 mM K 2 HPO 4 , 5 mM succinic acid, 5 mM malic acid, 1 mM MgCl 2 , 20 mM HEPES, 1 mM pyruvate, 0.5 mM ATP and 0.1 mM ADP (pH 7 at 37 uC). Intracellular buffer was supplemented with either 100 mM EGTA (intracellular buffer/EGTA) or a 2 mM EGTA and 2 mM HEEDTA-buffered [Ca 21 ] of 2 or 3 mM (intracellular buffer/Ca 21 ), calculated with the Chelator software 28 . HeLa cells were permeabilized by a 1-min perfusion with 50 mM digitonin (added to intracellular buffer/EGTA) during luminescence measurements. Mitochondrial Ca 21 uptake speed was calculated as the first derivative by using the SLOPE Excel function (Microsoft) and smoothed for three time points. The higher value reached during Ca 21 addition represents the maximal Ca 21 uptake speed.
[Ca 21 ] mt following capacitative Ca 21 influx was measured by perfusing HeLa cells with the SERCA blocker cyclopiazonic acid (CPA, 20 mM) in a KRB solution containing no Ca 21 and 100 mM EGTA. In this protocol, mitochondrial Ca 21 uptake were evoked by adding 2 mM CaCl 2 to the medium. All of the results are expressed as means 6 s.e.m., and Student's t-test was used for the statistics. All the materials were from Sigma Aldrich unless specified. Mitochondrial and endoplasmic reticulum morphology analysis. Images for investigating mitochondrial morphology and endoplasmic reticulum/mitochondrial contact sites were taken on a Leica TCS-SP5-II equipped with a PlanApo 1003/1.4 numerical aperture objective. For all images, pinhole was set to 1 Airy unit, pixel size was 75 nm and a Z-stack was acquired for the whole depth of the cell by sampling at 130 nm in the Z plane. An argon laser line (488 nm) was used to excite GFP or AlexaFluor488 and the signal was collected in the 492-537 nm range, whereas RFP (and MitoTracker Red and AlexaFluor546) fluorescence was excited by the 543 nm HeNe laser and its emission was collected in the 555-700 nm range. For each image, PMT gain was slightly adjusted in order to maximize signal and avoid saturation. Images were then all analysed with the Fiji image processing package based on ImageJ. Mitochondrial morphology was calculated with the 3D Object Counter plugin, and colocalization was evaluated with the JaCoP plugin 29 . The colocalization index is represented by Pearson's coefficient calculated following Costes randomization (100 cycles) and automatic threshold calculation 30 . Immunofluorescence. HeLa cells were grown on 24-mm coverslips and transfected with MCU-Flag encoding plasmid when 50% confluent. After 24 h, cells were washed with PBS, fixed in 4% formaldehyde for 10 min and quenched with 50 mM NH 4 Cl in PBS. Cells were permeabilized for 10 min with 0.1% Triton X-100 in PBS and blocked in PBS containing 2% BSA and 0.05% Triton X-100 LETTER RESEARCH
